Today at #AACR26, @samuels_yardena discusses revisiting the neoantigen approach to cancer immunotherapy - read more in her @CD_AACR paper: Recurrent Immunogenic Neoantigens & Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer https://t.co/Z226zJegpH https://t.co/UhK07zptpy